Uzbekistan Pharma Serialization Begins Feb. 1, 2022

The Republic of Uzbekistan's Cabinet of Ministers issued Resolution No. 149 on April 2, 2022, which was titled "On the Introduction of a System of Mandatory Digital Labelling of Medicines and Medical Devices." The proposal calls for a system of mandatory digital labelling to be phased in between 2022 and 2025, taking into account categories of medications (with the exception of drugs) and medical devices. It is the most recent deadline for compliance in the nation's campaign for serialisation and digital marking legislation, which will have an impact on a variety of industries.

The four classes into which the products that will be labelled are the following:

• Group-1: Pharmaceuticals packaged in secondary (external) form (excluding orphan medications)
• Group-2: Pharmaceutical drugs in main (internal) packaging (assuming that there is no secondary (external) packaging) (except orphan drugs)
• Group-3: a) Medications listed in the registry of medications with international registrations, the results of which are recognised in Uzbekistan.
  b) medications and medical equipment for orphan diseases (in accordance with the list approved by the Ministry of Health)
• Group-4: In accordance with the Ministry of Health's list of approved medicinal supplies.

Why Track & Trace ?

For companies who wish to secure their supply chains with the greatest digital technologies and solutions, Track & Trace has built end-to-end traceability and compliance centres.

To find out more about our traceability and compliance solutions, get in touch with us right away. Our award-winning Traceability System will be briefly shown by our digital supply chain experts, who will also demonstrate how to be legal and adaptable wherever you conduct business.

With the aim of ensuring consumers the declared quality and authenticity of the products they purchase that are imported or produced on the soil of the Republic of Uzbekistan.